Peptidoglycan-induced modulation of metabolic and inflammatory responses. Issue 2 (28th April 2023)

• Record Type: Journal Article
• Authors: Wolf, Andrea J.
• Is Part Of: Immunometabolism. Volume 5:Issue 2(2023)
• Page Start: e00024
• Publication Date: 2023-04-28
• Subjects: peptidoglycan -- MDP -- NOD1 -- NOD2 -- metabolism -- inflammation; 616.079
• DOI: 10.1097/IN9.0000000000000024
• Languages: English
• ISSNs: 2633-0407

Abstract

Abstract : Bacterial cell wall peptidoglycan is composed of innate immune ligands and, due to its important structural role, also regulates access to many other innate immune ligands contained within the bacteria. There is a growing body of literature demonstrating how innate immune recognition impacts the metabolic functions of immune cells and how metabolic changes are not only important to inflammatory responses but are often essential. Peptidoglycan is primarily sensed in the context of the whole bacteria during lysosomal degradation; consequently, the innate immune receptors for peptidoglycan are primarily intracellular cytosolic innate immune sensors. However, during bacterial growth, peptidoglycan fragments are shed and can be found in the bloodstream of humans and mice, not only during infection but also derived from the abundant bacterial component of the gut microbiota. These peptidoglycan fragments influence cells throughout the body and are important for regulating inflammation and whole-body metabolic function. Therefore, it is important to understand how peptidoglycan-induced signals in innate immune cells and cells throughout the body interact to regulate how the body responds to both pathogenic and nonpathogenic bacteria. This mini-review will highlight key research regarding how cellular metabolism shifts in response to peptidoglycan and how systemic peptidoglycan sensing impacts whole-body metabolic function.